Immunotherapy: HLA genotype: good to be different

Nature Reviews Immunology 18, 78 (2018). doi:10.1038/nri.2017.220 Author: Kirsty Minton HLA class I homozgosity and loss of heterozygosity are associated with poor response to checkpoint blockade therapy.
Source: Nature Reviews Immunology - Category: Allergy & Immunology Authors: Tags: Research Highlight Source Type: research